Pharmacist Help (09885) released its interim performance for the six months ended June 30, 2024. The group generated revenue of RMB 8.814 billion, a year-on-year increase of 10.6%. The adjusted net profit was RMB 91.411 million, an increase of 30.3% year-on-year. The profit attributable to owners of the company was RMB 21.82 million, compared to a loss of RMB 3.169 billion in the same period last year. Earnings per share were 0.03 yuan.

During the reporting period, the company's business continued to maintain high-quality growth. The company's total GMV was RMB 23.83 billion, an increase of 8.1% year-on-year. Based on the continuous expansion of the pharmaceutical and health product matrix and the continuous improvement of user experience, the company has built a high-sticky and highly active quality user ecosystem. As of June 30, 2024, the company has accumulated over 0.741 million registered buyers, including approximately 0.426 million pharmacies and over 0.31 million grassroots medical institutions. During the reporting period, the company's average monthly active buyers exceeded 0.425 million, an increase of 20.4% year-on-year. The average monthly paid buyers reached 0.396 million, an increase of 19.6% year-on-year. The company's payment rate, the ratio of average monthly paid buyers to average monthly active buyers, exceeded 93%, with each paid buyer averaging about 28 orders per month.

Platform business is the foundation for ensuring the company's continued growth. By relying on internet technology, the company has built an online trading platform that connects upstream pharmaceutical suppliers with downstream pharmacies and grassroots medical institutions. On the one hand, the company continuously upgrades the fine digital operation system provided to pharmaceutical companies and dealers, attracting more third-party merchants to join the platform and providing downstream users with a more diverse range of pharmaceutical and health products; on the other hand, the company allows pharmacies and grassroots medical institutions nationwide to directly connect with a broader range of upstream suppliers. Through the online trading platform, buyers and sellers can easily complete processes such as product information inquiry, ordering, payment, and logistics tracking, greatly improving transaction efficiency. As of June 30, 2024, the company has attracted approximately 8,900 upstream sellers and over 0.741 million downstream buyers to trade on its platform. During the reporting period, the GMV of third-party merchants in the company's platform business was RMB 14.234 billion, accounting for 59.7% of the total GMV, an increase of 5.1% year-on-year.